AI 채팅
Loading data for TCMD — first visit, this takes a few seconds.

Tactile Systems Technology, Inc.

TCMD · NasdaqGM · USD

22.51 -0.06 (-0.27%)

종가 기준: Sep 15, 2026, 8:00 PM

시가총액
$509.9M

Tactile Systems Technology, Inc.(TCMD) 주가, 분석 및 데이터

내재가치

내재 가치 로딩 중…

애널리스트 전망

주가 전망 →

애널리스트 전망 없음

12개월 목표가 · 애널리스트 n/a명

애널리스트 컨센서스: n/a

간격:1D
캔들과 신호 불러오는 중…

재무 실적

재무 정보 보기 →
매출 (ttm)
$350.3M

불러오는 중...

최근 실적

발표치예상 대비전년 대비
매출$85.70Mn/a+8.61%
EPS$0.36+$0.19+427.27%

다음 실적 발표

장 마감 후입니다.

예상치 · 업그레이드 →

실적 상세 보기 →

지표

매수호가
21.66
순이익 (ttm)
24.9M
0.79
1.07
21.04
15.47
P/B (ttm)
2.28
P/S (ttm)
1.46
실적 발표일
May 4, 2026
매도호가
38.01
거래량
191,038
평균 거래량 (20일)
300,620
시가
22.48
전일 종가
22.57
일중 범위
22.25 - 22.63
52주 범위
13.38 - 37.77
배당
n/a
배당락일
n/a

Tactile Systems Technology, Inc. 소개

기업 정보 보기 →
Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema, phlebolymphedema, lipedema, venous insufficiencies, and other types of edema and leg ulcers; Entre Plus System, a pneumatic compression device for the at-home treatment of lymphedema, chronic edema, venous insufficiency, and chronic wounds. The company also provides Nimbl, a pneumatic compression platform for the treatment of upper extremity lymphedema; Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders. Tactile Systems Technology, Inc. was incorporated in 1995 and is headquartered in Minneapolis, Minnesota. Medical Devices · Healthcare

Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema, phlebolymphedema, lipedema, venous insufficiencies, and other types of edema and leg ulcers; Entre Plus System, a pneumatic compression device for the at-home treatment of lymphedema, chronic edema, venous insufficiency, and chronic wounds. The company also provides Nimbl, a pneumatic compression platform for the treatment of upper extremity lymphedema; Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders. Tactile Systems Technology, Inc. was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.

섹터 Healthcare
IPO 일자 Jul 28, 2016
직원 수 1,086
상장 거래소 NasdaqGM
티커 TCMD